•
Jun 30, 2012

Jazz Pharmaceuticals Q2 2012 Earnings Report

Total Revenue
$130M
Previous year: $64.6M
+100.6%
EPS
$1.09
Previous year: $0.81
+34.6%
Gross Profit
$114M
Previous year: $61.2M
+86.6%
Cash and Equivalents
$155M
Previous year: $102M
+50.9%
Total Assets
$1.7B
Previous year: $193M
+777.9%

Jazz Pharmaceuticals

Jazz Pharmaceuticals